BL Pharmtech, E.Leclerc Sign 'K-Food' Business Agreement

• 김지완
• 2025.03.21
• 오후 03:16

How Long Will “Split Listings” Undermine Biotech Trust?

• 류성
• 2025.03.20
• 오전 08:34

• SamsungBiologics
• JohnRim
• CDMO

Samsung Biologics CEO, “Plant 5 to Be Completed in April, Expanding Orders to Global Top 40”

• 송영두
• 2025.03.17
• 오후 12:53

• K-bio
• Syntekabio
• Curexo
• CorelineSoft

Coreline Soft Surges...Syntekabio·Curexo on the Rise[K-Bio Pulse]

• 김승권
• 2025.03.17
• 오전 10:40

• BainCapital
• MBK
• Classys

The Midas Touch in Biotech, How Bain Capital Differs From MBK

• 송영두
• 2025.03.17
• 오전 09:18

• CellBion
• HLB
• RPT

CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse]

• 나은경
• 2025.03.14
• 오전 07:58

Biosolution Releases U.S. Phase 2 Interim Results

• 석지헌
• 2025.03.13
• 오전 09:44

Antrogen Nears Approval in Japan [K-Bio Pulse]

• 김지완
• 2025.03.13
• 오전 08:08

• Celltrion
• OMLYCLO
• Xolair

Celltrion Wins FDA Nod for Xolair Biosimilar OMLYCLO

• 송영두
• 2025.03.12
• 오전 10:40

• DaehwaPharmaceutical
• DaebongLS
• HuonsGlobal

China Market Boosts Daehwa's Outlook, Targeting W200b[K-Bio Pulse]

• 유진희
• 2025.03.12
• 오전 07:56